CC BY 4.0 · Rev Bras Ginecol Obstet 2020; 42(06): 325-332
DOI: 10.1055/s-0040-1712129
Original Article
Contraception
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Results of the Insertion of Hysteroscopic Sterilization Devices in a Brazilian Public Hospital

Resultados da inserção de dispositivos de esterilização histeroscópica em um hospital público brasileiro
1   Department of General Surgery ad Specialty, Universidade Federal Fluminense, Niterói, RJ, Brazil
,
2   Department of Obstetrics, Hospital da Mulher Mariska Ribeiro, Rio de Janeiro, RJ, Brazil
,
1   Department of General Surgery ad Specialty, Universidade Federal Fluminense, Niterói, RJ, Brazil
› Author Affiliations
Further Information

Publication History

10 November 2019

23 March 2020

Publication Date:
30 June 2020 (online)

Abstract

Objective To evaluate the insertion of the hysteroscopic intratubal sterilization device for female sterilization concerning the technique and the feasibility.

Methods Retrospective study with data collection of medical records of 904 patients who underwent device insertion between January and September 2016 in a public hospital in Rio de Janeiro (Brazil) with data analysis and descriptive statistics.

Results In 85.8% of the cases, the uterine cavity was normal, and the most commonly-described findings upon hysteroscopy were synechiae (9.5%). The procedure lasted an average of 3.56 minutes (range: 1 to 10 minutes), and the pain was considered inexistent or mild in 58,6% of the cases, mild or moderate in 32,8%, and severe or agonizing in less than 1% (0.8%) of the cases, based on a verbal scale ranging from 0 to 10. The rate of successful insertions was of 85.0%, and successful tubal placement was achieved in 99.5% of the cases. There were no severe complications related to the procedure, but transient vasovagal reactions occurred in 5 women (0.6%).

Conclusion Female sterilization performed by hysteroscopy is a safe, feasible, fast, and well-tolerated procedure. The rates of successful insertions and tubal placements were high. There were few and mild adverse effects during the procedure, and there were no severe complications on the short term.

Resumo

Objetivo Avaliar a inserção de dispositivo intratubário de esterilização histeroscópica com relação à viabilidade e à técnica.

Métodos Estudo retrospectivo com coleta de dados de prontuários das pacientes submetidas à inserção do dispositivo entre janeiro e setembro de 2016 em um hospital público do Rio de Janeiro, com análise dos dados e realização de estatísticas descritivas.

Resultados Foram incluídos 904 casos no estudo. Em 85,8% dos casos, a cavidade uterina estava normal, e os achados mais comumente descritos à histeroscopia foram as sinequias (9,5%). O tempo médio do procedimento foi de 3,56 minutos (gama: de 1 a 10 minutos); a dor foi considerada de ausente a leve em 58,6% dos casos, de leve a moderada em 32,8% dos casos, e de forte à pior dor possível em menos de 1% dos casos (0,8%). A taxa de inserções bem-sucedidas foi de 85,0%, e a colocação tubária foi bem-sucedida em 99,5% dos casos. Não foram identificadas complicações graves, mas reações vasovagais transitórias ocorreram em 5 mulheres (0,6%).

Conclusão A esterilização feminina por histeroscopia é um procedimento seguro, viável, rápido, e bem tolerado. As taxas de inserção bem-sucedida e de colocação tubária foram altas. Houve poucos e leves efeitos colaterais durante o procedimento, e não foram observadas complicações graves no curto prazo.

Contributors

All of the authors contributed with the project and data interpretation, the writing of the article, the critical review of the intellectual content, and with the final approval of the version to be published.


 
  • References

  • 1 Povedano B, Arjona JE, Velasco E, Monserrat JA, Lorente J, Castelo-Branco C. Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre. BJOG 2012; 119 (07) 795-799 . Doi: 10.1111/j.1471-0528.2012.03292.x
  • 2 Solà DV, Pardo SJ, Ricci AP, Guiloff FE. Nuevo método de esterilización ambulatoria y permanente con técnica histeroscópica, Essure. Rev Chil Obstet Ginecol 2005; 70 (01) 28-32
  • 3 Chern B, Siow A. Initial Asian experience in hysteroscopic sterilisation using the Essure permanent birth control device. BJOG 2005; 112 (09) 1322-1327 . Doi: 10.1111/j.1471-0528.2005.00436.x
  • 4 Ricci PA, Solà VD, Avilés LG, Pardo SJ. Control de dispositivos intratubários Essure mediante estudio de imágenes. Rev Chil Obstet Ginecol 2007; 72 (06) 397-401 . Doi: 10.4067/S0717-75262007000600007
  • 5 Sinha D, Kalathy V, Gupta JK, Clark TJ. The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation. BJOG 2007; 114 (06) 676-683 . Doi: 10.1111/j.1471-0528.2007.01351.x
  • 6 Munro MG, Nichols JE, Levy B, Vleugels MPH, Veersema S. Hysteroscopic sterilization: 10-year retrospective analysis of worldwide pregnancy reports. J Minim Invasive Gynecol 2014; 21 (02) 245-251 . Doi: 10.1016/j.jmig.2013.09.016
  • 7 Depes DdeB, Pereira AMG, Lippi UG, Martins JA, Lopes RGC. Initial experience with hysteroscopic tubal occlusion (Essure®). Einstein (Sao Paulo) 2016; 14 (02) 130-134 . Doi: 10.1590/S1679-45082016AO3717
  • 8 Franchini M, Zizolfi B, Coppola C. , et al. Essure permanent birth control, effectiveness and safety: an Italian 11-year survey. J Minim Invasive Gynecol 2017; 24 (04) 640-645 . Doi: 10.1016/j.jmig.2017.02.004
  • 9 Fernandez H, Legendre G, Blein C, Lamarsalle L, Panel P. Tubal sterilization: pregnancy rates after hysteroscopic versus laparoscopic sterilization in France, 2006-2010. Eur J Obstet Gynecol Reprod Biol 2014; 180: 133-137 . Doi: 10.1016/j.ejogrb.2014.04.043
  • 10 Bernardo R, Vázquez-Carmino F. El sistema Essure® como método de esterilización femenina permanente. Clin Invest Ginecol Obstet 2010; 37 (06) 223-232 . Doi: 10.1016/j.gine.2009.05.005
  • 11 Leyser-Whalen O, Rouhani M, Rahman M, Berenson AB. Tubal risk markers for failure to place transcervical sterilization coils. Contraception 2012; 85 (04) 384-388 . Doi: 10.1016/j.contraception.2011.09.004
  • 12 Bettocchi S, Selvaggi L. A vaginoscopic approach to reduce the pain of office hysteroscopy. J Am Assoc Gynecol Laparosc 1997; 4 (02) 255-258 . Doi: 10.1016/s1074-3804(97)80019-9
  • 13 Vilos GA, Abu-Rafea B. New developments in ambulatory hysteroscopic surgery. Best Pract Res Clin Obstet Gynaecol 2005; 19 (05) 727-742 . Doi: 10.1016/j.bpobgyn.2005.06.012
  • 14 Duffy S, Marsh F, Rogerson L. , et al. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. BJOG 2005; 112 (11) 1522-1528 . Doi: 10.1111/j.1471-0528.2005.00726.x
  • 15 Syed R, Levy J, Childers ME. Pain associated with hysteroscopic sterilization. JSLS 2007; 11 (01) 63-65
  • 16 Levie MD, Chudnoff SG. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Minim Invasive Gynecol 2005; 12 (04) 318-322 . Doi: 10.1016/j.jmig.2005.05.016
  • 17 la Chapelle CF, Veersema S, Brölmann HAM, Jansen FW. Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis. Fertil Steril 2015; 103 (06) 1516-25.e1-3 . Doi: 10.1016/j.fertnstert.2015.03.009
  • 18 Kerin JF, Levy BS. Ultrasound: an effective method for localization of the echogenic Essure sterilization micro-insert: correlation with radiologic evaluations. J Minim Invasive Gynecol 2005; 12 (01) 50-54 . Doi: 10.1016/j.jmig.2004.12.009
  • 19 Veersema S, Vleugels MP, Timmermans A, Brölmann HAM. Follow-up of successful bilateral placement of Essure microinserts with ultrasound. Fertil Steril 2005; 84 (06) 1733-1736 . Doi: 10.1016/j.fertnstert.2005.05.047
  • 20 Thiel JA, Suchet IB, Lortie K. Confirmation of Essure microinsert tubal coil placement with conventional and volume-contrast imaging three-dimensional ultrasound. Fertil Steril 2005; 84 (02) 504-508 . Doi: 10.1016/j.fertnstert.2005.01.135
  • 21 Sagili H, Divers M. Hysteroscopic sterilisation with Essure: a promising new alternative to tubal ligation?. J Fam Plann Reprod Health Care 2008; 34 (02) 99-102 . Doi: 10.1783/jfp.34.2.99
  • 22 Connor VF. Contrast infusion sonography to assess microinsert placement and tubal occlusion after Essure. Fertil Steril 2006; 85 (06) 1791-1793 . Doi: 10.1016/j.fertnstert.2005.10.075
  • 23 Connor VF. Essure: a review six years later. J Minim Invasive Gynecol 2009; 16 (03) 282-290 . Doi: 10.1016/j.jmig.2009.02.009
  • 24 Veersema S, Vleugels M, Koks C, Thurkow A, van der Vaart H, Brölmann H. Confirmation of Essure placement using transvaginal ultrasound. J Minim Invasive Gynecol 2011; 18 (02) 164-168 . Doi: 10.1016/j.jmig.2010.10.010
  • 25 Lorente Ramos RM, Azpeitia Armán J, Rodríguez-Miñón PA, Salazar Arquero FJ, Albillos Merino JC. Valoración radiológica del anticonceptivo permanente de inserción histeroscópica Essure. Radiologia (Madr) 2015; 57 (03) 193-200 . Doi: 10.1016/j.rx.2014.12.006
  • 26 Mao J, Guiahi M, Chudnoff S, Schlegel P, Pfeifer S, Sedrakyan A. Seven-year outcomes after hysteroscopic and laparoscopic sterilizations. Obstet Gynecol 2019; 133 (02) 323-331 . Doi: 10.1097/AOG.0000000000003092
  • 27 Bouillon K, Bertrand M, Bader G, Lucot JP, Dray-Spira R, Zureik M. Association of hysteroscopic vs laparoscopic sterilization with procedural, gynecological, and medical outcomes. JAMA 2018; 319 (04) 375-387 . Doi: 10.1001/jama.2017.21269